Health Care Equipment & Services

Teladoc Health stock dips yet remains a key telehealth player—why investors are watching its loss‑filled metrics and upcoming Medicare changes.

Vitalhub Corp’s volatile stock swings reveal the risks for healthcare software firms—find out how its latest Q3 results and market trends shape future prospects.

Cyclopharm raises A$14 million and launches a share purchase plan to boost US expansion of its Technegas® radiopharmaceutical, driving growth and investor confidence.

Hoya Corp’s Q4 profit jump shows how the Tokyo‑listed optics and health‑care leader is boosting margins and shareholder value with diversified products and tech innovation.

DaVita’s Q4 2025 earnings beat expectations, with $2.34B revenue and $3.29 EPS, and a new Elara Caring investment signals growth in home‑based dialysis services.

Investors eye Nakamoto Inc.: a Nasdaq health‑care stock sees volatile lows, a delayed Q3 earnings due to merger‑accounting woes, and a negative P/E that signals risk and growth uncertainty.

Hydreight Technologies Inc. raises $15 M in an oversubscribed life‑style deal, driving a 350‑P/E, 16‑P/B valuation that signals high growth expectations and strong investor interest in its Canadian healthcare strategy.

Ardent Health Inc. faces a securities fraud lawsuit, class‑action deadline March 9, 2026, and falling stock—investors urged to act now to protect their shares.

Discover why institutional investors and analysts are bullish on Stryker Corp, the $135 billion medical‑device leader, after its Q4 2025 earnings beat and upgraded price targets.

Humana Inc. faces mixed investor sentiment—net sell‑side pressure and neutral analyst outlook—while its core health‑care strengths remain intact.